These collective findings suggest that dysregulation of GRAF1 phosphorylation may contribute to the exacerbation of cardiac diseases and potentially other conditions associated with defects in PINK1/Parkin-mediated mitochondrial quality control. This evidence concerns the gene ARHGAP26 and heart disorder.